image: Designer erythromycin analogues show activity against resistant bacteria. This material relates to a paper that appeared in the May 29, 2015, issue of Science, published by AAAS. The paper, by G. Zhang at University at Buffalo, The State University of New York in Buffalo, NY, and colleagues was titled, "Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli." view more
Credit: [Credit: Zhang, <i>et al.</i> Sci. Adv. 2015;1:e1500077]